Pulse Check: BIO leadership shakeup followed clashes with board

For the Oct. 31, 2022 episode, I spoke with Politico’s Megan R. Wilson about the aftermath of the departure of the CEO of the leading industry group for biopharmaceutical companies. Additionally, we hear from Chris Hammond, a Covid long-hauler, shares what life has been like for him, the Johns Hopkins trials he's a part of, and why he's not optimistic about additional Covid funding from Congress.